These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11722650)

  • 1. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
    Galvão da Silva AP; de Almeida Abrahamsohn I
    Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA; Coffman RL
    J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS; Tarleton RL
    J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
    Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
    Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
    Antúnez MI; Cardoni RL
    Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi.
    Abrahamsohn IA; da Silva AP; Coffman RL
    Infect Immun; 2000 Apr; 68(4):1975-9. PubMed ID: 10722591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen.
    de Barros-Mazon S; Guariento ME; Abrahamsohn IA
    Immunol Lett; 1997 Jun; 57(1-3):39-45. PubMed ID: 9232423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi.
    Leite de Moraes MD; Minoprio P; Dy M; Dardenne M; Savino W; Hontebeyrie-Joskowicz M
    Scand J Immunol; 1994 Jan; 39(1):51-8. PubMed ID: 8290893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin.
    Alcaide P; Fresno M
    Int Immunol; 2004 Oct; 16(10):1365-75. PubMed ID: 15314038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection.
    Pinge-Filho P; Tadokoro CE; Abrahamsohn IA
    Cell Immunol; 1999 Apr; 193(1):90-8. PubMed ID: 10202116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
    Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
    J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 reduces resistance of mice to Trypanosoma cruzi infection.
    Hiyama K; Hamano S; Nakamura T; Nomoto K; Tada I
    Parasitol Res; 2001 Apr; 87(4):269-74. PubMed ID: 11355674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.